These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 6609360)

  • 1. Thymus-derived lymphocytes and their interactions with macrophages are required for the production of osteoclast-activating factor in the mouse.
    Horowitz M; Vignery A; Gershon RK; Baron R
    Proc Natl Acad Sci U S A; 1984 Apr; 81(7):2181-5. PubMed ID: 6609360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Observations on the mechanism of bone resorption induced by multiple myeloma marrow culture fluids and partially purified osteoclast-activating factor.
    Josse RG; Murray TM; Mundy GR; Jez D; Heersche JN
    J Clin Invest; 1981 May; 67(5):1472-81. PubMed ID: 6262378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monocytes regulate osteoclast-activating factor production by releasing prostaglandins.
    Yoneda T; Mundy GR
    J Exp Med; 1979 Aug; 150(2):338-50. PubMed ID: 458377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nitric oxide production is required for murine resident peritoneal macrophages to suppress mitogen-stimulated T cell proliferation. Role of IFN-gamma in the induction of the nitric oxide-synthesizing pathway.
    Albina JE; Abate JA; Henry WL
    J Immunol; 1991 Jul; 147(1):144-8. PubMed ID: 1904899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production of human/mouse hybridomas secreting a human lymphokine, osteoclast activating factor.
    Nedwin GE; Mohler MA; Luben RA
    Cell Immunol; 1984 Apr; 84(2):324-32. PubMed ID: 6368007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of bone resorbing activity by normal and rheumatoid arthritis T cells.
    Flescher E; Garrett IR; Mundy GR; Talal N
    Clin Immunol Immunopathol; 1990 Aug; 56(2):210-8. PubMed ID: 2143127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Release of the lymphokine osteoclast activating factor requires cyclic AMP accumulation.
    Yoneda T; Mundy GR
    Calcif Tissue Int; 1982 Mar; 34(2):204-8. PubMed ID: 6177386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production of osteoclast-activating factor by normal human peripheral blood rosetting and nonrosetting lymphocytes.
    Chen P; Trummel C; Horton J; Baker JJ; Oppenheim JJ
    Eur J Immunol; 1976 Oct; 6(10):732-6. PubMed ID: 797286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of osteoclast-activating factor activity of multiple myeloma bone marrow cells by different interleukin-1 inhibitors.
    Torcia M; Lucibello M; Vannier E; Fabiani S; Miliani A; Guidi G; Spada O; Dower SK; Sims JE; Shaw AR; Dinarello CA; Garaci E; Cozzolino F
    Exp Hematol; 1996 Jul; 24(8):868-74. PubMed ID: 8690044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positively selected Lyt-2+ and Lyt-2- mouse T lymphocytes are comparable, after Con A stimulation, in release of IL 2 and of lymphokines acting on B cells, macrophages, and mast cells, but differ in interferon production.
    Guerne PA; Piguet PF; Vassalli P
    J Immunol; 1983 May; 130(5):2225-30. PubMed ID: 6187845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulated rat T cell-derived inhibitory factor for cellular DNA synthesis (STIF). III. Effect on cell proliferation and immune responses.
    Chiba K; Nishimura T; Hashimoto Y
    J Immunol; 1985 May; 134(5):3172-8. PubMed ID: 2580017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of macrophages in thymocyte mitogenesis.
    Mills G; Monticone V; Paetkau
    J Immunol; 1976 Oct; 117(4):1325-30. PubMed ID: 1086324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonspecific activation of murine lymphocytes. VI. Mediation of synergistic interaction between T and B lymphocytes by a cell-associated, reciprocally acting lymphocyte proliferation helper.
    Goodman MG; Weigle WO
    J Exp Med; 1979 Mar; 149(3):644-57. PubMed ID: 311812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proliferation of murine thymic lymphocytes in vitro is mediated by the concanavalin A-induced release of a lymphokine (costimulator).
    Paetkau V; Mills G; Gerhart S; Monticone V
    J Immunol; 1976 Oct; 117(4):1320-4. PubMed ID: 1086323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of macrophage Fc-dependent phagocytosis by resident thymocytes: effect of a unique heat-stable lymphokine.
    Coleman DL; Root RK; Ryan JL
    J Immunol; 1983 May; 130(5):2195-9. PubMed ID: 6339624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T and B cells induce macrophages which suppress proliferation but not lymphokine secretion.
    Li W; Miller RA
    Cell Immunol; 1984 Sep; 87(2):366-78. PubMed ID: 6235922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphocyte activating factor promotes T-cell growth factor production by cloned murine lymphoma cells.
    Smith KA; Gilbride KJ; Favata MF
    Nature; 1980 Oct; 287(5785):853-5. PubMed ID: 6776414
    [No Abstract]   [Full Text] [Related]  

  • 18. Influence of various macrophage populations on Con-A induced T-cell proliferation.
    Knop J
    Immunology; 1980 Oct; 41(2):379-85. PubMed ID: 6969220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune interferon. II. Different cellular site for the production of murine macrophage migration inhibitory factor and interferon.
    Neumann C; Sorg C
    Eur J Immunol; 1978 Aug; 8(8):582-9. PubMed ID: 359337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purification and partial sequence of human osteoclast-activating factor: identity with interleukin 1 beta.
    Dewhirst FE; Stashenko PP; Mole JE; Tsurumachi T
    J Immunol; 1985 Oct; 135(4):2562-8. PubMed ID: 3875658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.